Beneficial effects of aminoguanidine on skin flap survival in diabetic rats

Experimental Diabetes Research

Volumn 2012, Issue , 2012, Pages

  Ozturk, Ayse ^a   Firat, Cemal ^a,b   Parlakpinar, Hakan ^a   Bay Karabulut, Aysun ^a   Kirimlioglu, Hale ^a   Gurlek, Ali ^a  

^a INONU UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b INONU UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGUANIDINE; FREE RADICAL; GLUTATHIONE; MALONALDEHYDE; NITRIC OXIDE; SUPEROXIDE DISMUTASE; ANTIOXIDANT; GLYCOSYLATED HEMOGLOBIN; GUANIDINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG RESPONSE; ENZYME ACTIVITY; FEMALE; GRAFT NECROSIS; GRAFT REJECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SKIN FLAP SURVIVAL; SKIN PROTECTION; ANIMAL; BLOOD; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; METABOLISM; MICROCIRCULATION; NECROSIS; PATHOLOGY; SKIN; SURGICAL FLAPS; VASCULARIZATION; WISTAR RAT;

ANIMALS; ANTIOXIDANTS; BLOOD GLUCOSE; DIABETES COMPLICATIONS; DIABETES MELLITUS, EXPERIMENTAL; FEMALE; GLUTATHIONE; GUANIDINES; HEMOGLOBIN A, GLYCOSYLATED; MALONDIALDEHYDE; MICROCIRCULATION; NECROSIS; NITRIC OXIDE; OXIDATIVE STRESS; RATS; RATS, WISTAR; SKIN; SUPEROXIDE DISMUTASE; SURGICAL FLAPS;

MLCS; MLOWN;

EID: 84872153474     PISSN: 16875214     EISSN: 16875303     Source Type: Journal    
DOI: 10.1155/2012/721256     Document Type: Article

References (36)

1. Kennedy L., Baynes J. W., Non-enzymatic glycosylation and the chronic complications of diabetes: an overview. Diabetologia 1984 26 2 93 98 2-s2.0-0021320701 (Pubitemid 14190663)
2. Vlassara H., Palace M. R., Glycoxidation: the menace of diabetes and aging. Mount Sinai Journal of Medicine 2003 70 4 232 241 2-s2.0-0142124436 (Pubitemid 37321701)
3. Sun F., Iwaguchi K., Shudo R., Nagaki Y., Tanaka K., Ikeda K., Tokumaru S., Kojo S., Change in tissue concentrations of lipid hydroperoxides, vitamin C and vitamin E in rats with streptozotocin-induced diabetes. Clinical Science 1999 96 2 185 190 2-s2.0-0032969641 (Pubitemid 29094938)
4. Thornalley P. J., Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts. Archives of Biochemistry and Biophysics 2003 419 1 31 40 2-s2.0-0142074864 10.1016/j.abb.2003.08.013 (Pubitemid 37279141)
5. Katz A., Ekberg K., Johansson B. L., Wahren J., Diminished skin blood flow in type I diabetes: evidence for non-endothelium-dependent dysfunction. Clinical Science 2001 101 1 59 64 2-s2.0-0034931083 10.1042/CS20010003 (Pubitemid 32634738)
6. Khan F., Elhadd T. A., Greene S. A., Belch J. J. F., Impaired skin microvascular function in children, adolescents, and young adults with type I diabetes. Diabetes Care 2000 23 2 215 220 2-s2.0-0033980447 (Pubitemid 30071027)
7. Myers M. B., Cherry G., Causes of necrosis in pedicle flaps. Plastic and Reconstructive Surgery 1968 42 1 43 50 2-s2.0-0014302236
8. Kerrigan C. L., Skin flap failure: pathophysiology. Plastic and Reconstructive Surgery 1983 72 6 766 774 2-s2.0-0021068781 (Pubitemid 14216810)
9. Pang C. Y., Forrest C. R., Neligan P. C., Lindsay W. K., Augmentation of blood flow in delayed random skin flaps in the pig: effect of length of delay period and angiogenesis. Plastic and Reconstructive Surgery 1986 78 1 68 74 2-s2.0-0022508227 (Pubitemid 16066032)
10. O'Toole G., MacKenzie D., Poole M., Buckley M. F., Lindeman R., A review of therapeutic angiogenesis and consideration of its potential applications to plastic and reconstructive surgery. British Journal of Plastic Surgery 2001 54 1 1 7 2-s2.0-0035168220 10.1054/bjps.2000.3454 (Pubitemid 32049150)
11. Misko T. P., Moore W. M., Kasten T. P., Nickols G. A., Corbett J. A., Tilton R. G., McDaniel M. L., Williamson J. R., Currie M. G., Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. European Journal of Pharmacology 1993 233 1 119 125 2-s2.0-0027402115 (Pubitemid 23091752)
12. Sugimoto K., Yagihashi S., Effects of aminoguanidine on structural alterations of microvessels in peripheral nerve of streptozotocin diabetic rats. Microvascular Research 1997 53 2 105 112 2-s2.0-0031106418 10.1006/mvre.1996. 2002 (Pubitemid 27202426)
13. Tilton R. G., Chang K., Hasan K. S., Smith S. R., Petrash J. M., Misko T. P., Moore W. M., Currie M. G., Corbett J. A., McDaniel M. L., Williamson J. R., Prevention of diabetic vascular dysfunction by guanidines: inhibition of nitric oxide synthase versus advanced glycation end-product formation. Diabetes 1993 42 2 221 232 2-s2.0-0027400644 (Pubitemid 23045024)
14. Parlakpinar H., Ozer M. K., Acet A., Effect of aminoguanidine on ischemia-reperfusion induced myocardial injury in rats. Molecular and Cellular Biochemistry 2005 277 1-2 137 142 2-s2.0-24144461924 10.1007/s11010-005-5779-9 (Pubitemid 41236196)
15. Xu J., Li N., Dai D. Z., Yu F., Dai Y., The endothelin receptor antagonist CPU0213 is more effective than aminoguanidine to attenuate isoproterenol-induced vascular abnormality by suppressing overexpression of NADPH oxidas, ETA, ETB, and MMP9 in the vasculature. Journal of Cardiovascular Pharmacology 2008 52 1 42 48 2-s2.0-55949133542 10.1097/FJC.0b013e31817dfc8f
16. Khouri R. K., Angel M. F., Edstrom L. E., Standardizing the dorsal rat flap. Surgical Forum 1986 37 590 594
17. Uchiyama M., Mihara M., Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Analytical Biochemistry 1978 34 271 278 (Pubitemid 9050395)
18. Ellman G. L., Tissue sulfhydryl groups. Archives of Biochemistry and Biophysics 1959 82 70 77
19. Sun Y., Oberley L. W., Li Y., A simple method for clinical assay of superoxide dismutase. Clinical Chemistry 1988 34 3 497 500 2-s2.0-0023952554
20. McFarlane R. M., DeYoung G., Henry R. A., The design of a pedicle flap in the rat to study necrosis and its prevention. Plastic and Reconstructive Surgery 1965 35 177 182
21. Kdziora-Kornatowska K. Z., Luciak M., Błaszczyk J., Pawlak W., Effect of aminoguanidine on the generation of superoxide anion and nitric oxide by peripheral blood granulocytes of rats with streptozotocin-induced diabetes. Clinica Chimica Acta 1998 278 1 45 53 2-s2.0-0345487010 10.1016/S0009-8981(98) 00130-2 (Pubitemid 28544985)
22. Opara E. C., Oxidative stress, micronutrients, diabetes mellitus and its complications. Journal of The Royal Society for the Promotion of Health 2002 122 1 28 34 2-s2.0-0036113503 (Pubitemid 34406596)
23. Attinger C. E., Ducic I., Cooper P., Zelen C. M., The role of intrinsic muscle flaps of the foot for bone coverage in foot and ankle defects in diabetic and nondiabetic patients. Plastic and Reconstructive Surgery 2002 110 4 1047 1054 2-s2.0-0037105803 (Pubitemid 34913341)
24. Jakus V., Hrnciarova M., Carsky J., Inhibition of enzymatic proteinglycation and lipid peroxidation by drugs with antioxidant activity. Life Sciences 1999 65 1991 1993 (Pubitemid 29506943)
25. Parlakpinar H., Koc M., Polat A., Vardi N., Ozer M. K., Turkoz Y., Acet A., Protective effect of aminoguanidine against nephrotoxicity induced by amikacin in rats. Urological Research 2004 32 4 278 282 2-s2.0-4544383616 10.1007/s00240-004-0399-5 (Pubitemid 39222605)
26. Velazquez E., Winocour P. H., Kesteven P., Alberti K. G. M. M., Laker M. F., Relation of lipid peroxides to macrovascular disease in Type 2 diabetes. Diabetic Medicine 1991 8 8 752 758 2-s2.0-0025866522
27. Moncado S., Palmer R. M. J., Higgs E. A., Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacological Reviews 1991 43 109 142
28. Lipton S. A., Choi Y. B., Pan Z. H., Lei S. Z., Chen H. S. V., Sucher N. J., Loscalzo J., Singel D. J., Stamler J. S., A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 1993 364 6438 626 632 2-s2.0-0027194540 10.1038/364626a0 (Pubitemid 23274719)
29. Radi R., Beckman J. S., Bush K. M., Freeman B. A., Peroxynitrite oxidation of sulfhydryls: the cytotoxic potential of superoxide and nitric oxide. Journal of Biological Chemistry 1991 266 7 4244 4250 2-s2.0-0025730414 (Pubitemid 21909347)
30. Nilsson B. O., Biological effects of aminoguanidine: an update. Inflammation Research 1999 48 10 509 515 2-s2.0-0032697984 10.1007/s000110050495 (Pubitemid 29495631)
31. Hasan K., Heesen B. J., Corbett J. A., McDaniel M. L., Chang K., Allison W., Wolffenbuttel B. H. R., Williamson J. R., Tilton R. G., Inhibition of nitric oxide formation by guanidines. European Journal of Pharmacology 1993 249 1 101 106 2-s2.0-0027374229 10.1016/0014-2999(93)90667-7 (Pubitemid 23326915)
32. Oishi S. N., Levin L. S., Pederson W. C., Microsurgical management of extremity wounds in diabetics with peripheral vascular disease. Plastic and Reconstructive Surgery 1993 92 3 485 492 2-s2.0-0027317464 (Pubitemid 23230642)
33. Im M. J., Manson P. N., Bulkley G. B., Hoopes J. E., Effects of superoxide dismutase and allopurinol on the survival of acute island skin flaps. Annals of Surgery 1985 201 3 357 359 2-s2.0-0021885680 (Pubitemid 15010465)
34. Abou-Seif M. A. M., Youssef A. A., Oxidative stress and male IGF-1, gonadotropin and related hormones in diabetic patients. Clinical Chemistry and Laboratory Medicine 2001 39 7 618 623 2-s2.0-0034898708 10.1515/CCLM.2001.099 (Pubitemid 32725747)
35. Courderot-Masuyer C., Dalloz F., Maupoil V., Rochette L., Antioxidant properties of aminoguanidine. Fundamental and Clinical Pharmacology 1999 13 5 535 540 2-s2.0-0033303952
36. Oikawa K., Ohbayashi T., Mimura J., Fujii-Kuriyama Y., Teshima S., Rokutan K., Mukai K., Kuroda M., Dioxin stimulates synthesis and secretion of IgE-dependent histamine-releasing factor. Biochemical and Biophysical Research Communications 2002 290 3 984 987 2-s2.0-0036290405 10.1006/bbrc.2001.6302 (Pubitemid 34687459)